FRM 6308

Drug Profile

FRM 6308

Alternative Names: EVP-6308; FRM-6308

Latest Information Update: 09 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator EnVivo Pharmaceuticals
  • Developer FORUM Pharmaceuticals
  • Class Antipsychotics; Mood stabilisers
  • Mechanism of Action Phosphodiesterase 10A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 01 Jun 2016 Discontinued - Phase-I for Schizophrenia in USA (PO)
  • 26 Apr 2016 Phase I development is ongoing in USA
  • 30 Jun 2014 FORUM Pharmaceuticals completes a phase I trial in Healthy volunteers in USA (NCT02001389)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top